Epizyme
Why Robinhood?
You can watch Epizyme and buy or sell other stocks, ETFs, and their options commission-free!About EPZM
Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases.
EPZM Key Statistics
Stock Snapshot
As of today, Epizyme(EPZM) shares are valued at $1.47. The company's market cap stands at 247.44M, with a P/E ratio of -0.85.
On 2026-03-11, Epizyme(EPZM) stock opened at —, reached a high of —, and a low of —.
The Epizyme(EPZM)'s current trading volume is 0, compared to an average daily volume of 4.24M.
During the past year, Epizyme(EPZM) stock moved between $0.41 at its lowest and $5.80 at its peak.
During the past year, Epizyme(EPZM) stock moved between $0.41 at its lowest and $5.80 at its peak.
EPZM News
Hutchmed (HCM) announced an update regarding Tazverik, an oncology therapy licensed from Epizyme, an Ipsen (IPSEY) company, in China. Epizyme is the marketing a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.